Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Current opinions on diagnosis and treatment of adenoid cystic carcinoma.

Authors:
Yan Fang Zhouying Peng Yumin Wang Kelei Gao Yalan Liu Ruohao Fan Hua Zhang Zhihai Xie Weihong Jiang

Oral Oncol 2022 07 2;130:105945. Epub 2022 Jun 2.

Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Anatomy Laboratory of Division of Nose and Cranial Base, Clinical Anatomy Center of Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Electronic address:

Adenoid cystic carcinoma (ACC) is a rare malignant tumor derived mainly from the salivary glands, representing approximately 1% of all headandneck carcinomasand 10% of all salivary gland neoplasms. ACC displays a paradoxical behavioral combination of an indolent growth pattern but an aggressive progression, with local recurrence and distant metastasis. The propensity of ACC of the head and neck (ACCHN) for perineural invasion and its anatomical location, especially if it extends to the nasal cavity and paranasal sinuses, facilitates tumor involvement in the surrounding structures, such as the orbit, pterygopalatine fossa, Meckel'scave, and cavernous sinus, which can lead to skull base involvement and intracranial extension. Despite advances in molecular mechanisms and diagnostic imaging, ACC treatment remainschallenging due to the lack ofconsensuson treatment patterns. In this review, we aimed toprovideanupdatedinsight intothe understanding of ACCHN by focusing on clinical behavior, imaging diagnosis, pathological features, and therapeutic strategies. We reviewed the molecular mechanisms, especially in ACCHN with perineural invasion, and elaborated on treatment options, including chemotherapy, targeted therapies, and immunotherapy, to establish a comprehensive understanding of ACC to arrive at a policy for proper diagnosis, preoperative evaluation, and therapeutic strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2022.105945DOI Listing
July 2022

Publication Analysis

Top Keywords

cystic carcinoma
8
acchn perineural
8
perineural invasion
8
therapeutic strategies
8
adenoid cystic
8
molecular mechanisms
8
acc
5
skull base
4
base involvement
4
involvement intracranial
4
intracranial extension
4
extension despite
4
despite advances
4
evaluation therapeutic
4
advances molecular
4
sinus lead
4
mechanisms diagnostic
4
diagnostic imaging
4
imaging acc
4
acc treatment
4

Keyword Occurance

Similar Publications

Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy.

Authors:
Lixi Li Di Zhang Fei Ma

J Clin Med 2022 Jul 31;11(15). Epub 2022 Jul 31.

Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan Nan Road 17, Beijing 100021, China.

Consistent standards regarding whether postoperative adjuvant chemotherapy is required in the treatment of adenoid cystic carcinoma of the breast (ACCB) are currently lacking. Using clinical data from the Surveillance, Epidemiology, and End Results (SEER) database (1988-2015), and the National Cancer Center of China (2004-2020), we retrospectively analyzed patients with ACCB who received radical treatment. A total of 661 patients were eligible. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study.

Authors:
Marta Persson Mattias K Andersson Yoshitsugu Mitani Margaret S Brandwein-Weber Henry F Frierson Christopher Moskaluk Isabel Fonseca Renata Ferrarotto Werner Boecker Thomas Loening Adel K El-Naggar Göran Stenman

Cancers (Basel) 2022 Jul 28;14(15). Epub 2022 Jul 28.

Sahlgrenska Center for Cancer Research, Department of Pathology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.

Adenoid cystic carcinoma (ACC) is an aggressive head and neck malignancy characterized by a t (6;9) translocation resulting in an gene fusion or, more rarely, an fusion. The true frequency and clinical significance of these alterations are still unclear. Here, we have used tissue microarrays and analyzed 391 ACCs and 647 non-ACC salivary neoplasms to study the prevalence, expression, and clinical significance of alterations by FISH and immunohistochemistry. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.

Authors:
Anne Grabenstetter Edi Brogi Hong Zhang Pedram Razavi Jorge S Reis-Filho Kimberly J VanZee Larry Norton Hannah Y Wen

NPJ Breast Cancer 2022 Aug 11;8(1):93. Epub 2022 Aug 11.

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Breast adenoid cystic carcinoma (AdCC) is a rare subtype of triple negative breast cancer. Two morphologic variants are described, namely classic AdCC (C-AdCC) and solid basaloid (SB-AdCC). Recent studies have shown that the SB-AdCC variant has significantly worse prognosis than C-AdCC. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.

Authors:
Laura Feeney Brindley Hapuarachi Helen Adderley Sam Rack David Morgan Russell Walker Rami Rauch Elad Herz Joel Kaye Kevin Harrington Robert Metcalf

Oral Oncol 2022 Aug 8;133:106028. Epub 2022 Aug 8.

The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. Electronic address:

Background: Adenoid cystic carcinoma (ACC) is a rare salivary cancer. The highest rates of disease recurrence are in patients with NOTCH pathway activation, reported in up to 20%. Novel drugs targeting NOTCH signaling are under investigation in the recurrent/metastatic (R/M) setting. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

One-step Endovascular Aortic Aneurysm Repair With CO2 contrast and Robotic Partial Nephrectomy for Renal Cell Carcinoma: Case Report.

Authors:
Andressa C S Louzada Marina B Wolosker Rafael H Astolfi José Colombo Junior Omar R El Hayek Marcelo P Teivelis Nelson Wolosker

Vasc Endovascular Surg 2022 Aug 11:15385744221120975. Epub 2022 Aug 11.

Department of Vascular and Endovascular Surgery, 37896Hospital Israelita Albert Einstein, São Paulo, Brazil.

Introduction: Although rare, as the population ages, abdominal aortic aneurysm synchronous to abdominal malignancies, as renal cell carcinoma, is expected to become more prevalent. There are only two case reports of minimally invasive surgeries to treat these synchronous diseases, with endovascular aortic repair and laparoscopic nephrectomy, but they were performed in two stages, with iodinated contrast and without robotic assistance.

Case Report: We herein present a case of a 71-year-old patient with chronic kidney disease, a 6. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap